A parallel synthesis demonstration library of tri-substituted indazoles containing new antimutagenic/antioxidant hits related to benzydamine

Combinatorial Chemistry and High Throughput Screening

Volumn 6, Issue 5, 2003, Pages 471-480

  Menon, Sanjay ^a   Vaidya, Hemin ^a   Pillai, Segaran ^a   Vidya, Ramdas ^a   Mitscher, Lester A ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(2 FLUORO 5 NITROPHENYL) N (PHENYLAMINO)CARBOXAMIDE; (TERT BUTOXY) N [(2 FLUORO 5 NITROPHENYL)CARBONYLAMINO] N BENZYLCARBOXAMIDE; 1 BENZYL 3 (3 ETHOXY 1 METHYL 1H INDAZOL 5 YL)UREA; 1 BENZYL 3 ETHOXY 5 NITRO 1H INDAZOLE; 1 METHYL 5 NITRO 1H INDAZOL 3 OL; 1 METHYL 5 NITRO 2 BENZYL 1H 2 HYDROINDAZOL 3 ONE; 1 METHYL 5 NITRO 3 (PHENYLMETHOXY) 1H INDAZOLE; 2 ETHYL 1 METHYL 5 NITRO 1H 2 HYDROINDAZOL 3 ONE; 2 FLUORO 5 NITROBENZOYL CHLORIDE; 2,5 DIOXOAZOLIDINYL 2 FLUORO 5 NITROBENZOATE; 3 (3 DIMETHYLAMINOPROPOXY) 1 METHYL 1H INDAZOL 5 YLAMINE; 3 BROMO 1 METHYL 5 NITRO 1H INDAZOLE; 3 ETHOXY 1 METHYL 1H INDAZOL 5 YLAMINE; 3 ETHOXY 1 METHYL 5 NITRO 1H INDAZOLE; 5 NITRO 1 BENZYL 1H INDAZOL 3 OL; 5 NITRO 1 PHENYL 1H INDAZOL 3 OL; BENZYDAMINE; DIMETHYL[3 (1 METHYL 5 NITRO(1H INDAZOL 3 YLOXY)PROPYL]AMINE; INDAZOLE DERIVATIVE; METHYL 2 FLUORO 5 NITROBENZOATE; N (3 ETHOXY 1 METHYL 1H INDAZOL 5 YL) 4 METHYLBENZENE SULFONAMIDE; N AMINO(TERT BUTOXY) N BENZYLCARBOXAMIDE; N [3 ETHOXY 1 METHYL(1H INDAZOL 5 YL)]BENZAMIDE; REAGENT; TOLUENE 4 SULFONIC ACID 1 METHYL 5 NITRO 1H INDAZOL 3 YL ESTER; UNCLASSIFIED DRUG; [3 ETHOXY 1 METHYL(1H INDAZOL 5 YL)]BENZYLAMINE;

ACYLATION; ALKYLATION; ANTIMUTAGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL REACTION; DRUG ACTIVITY; DRUG SELECTIVITY; DRUG SYNTHESIS; FILTRATION; METHODOLOGY; PRIORITY JOURNAL; REDUCTION; SUBSTITUTION REACTION;

EID: 0043131850     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620703106298644     Document Type: Article

References (20)

1. Shankel, D. M.; Pillai, S. P.; Menon, S. R.; Pillai, C. A.; Mitscher, L. A. Biofactors 2000, 12, 113-121.
2. Fecik, R. A.; Frank, K. E.; Gentry, E. J.; Menon, S. R.; Mitscher, L. A.; Telikepalli, H. Med. Res. Rev. 1998, 18, 149-185.
3. Cioli, V.; Corradino, C.; De Martino, C.; Pasquini, P.; Rossi, V.; Silvestrini, B. Arzneimittelforschung 1984, 34, 455-460.
4. Mayer, B.; Klatt, P.; Werner, E. R.; Schmidt, K. Neuropharmacology 1994, 33, 1253-1259.
5. Mosti, L.; Menozzi, G.; Fossa, P.; Schenone, P.; Lampa, E.; Parrillo, C.; D'Amisco, M.; Rossi, F. Farmaco 1992, 47, 567-584.
6. Schindler, R.; Hoefgen, N.; Heinecke, K.; Poppe, H.; Szelenyi, I. Pharmazie 2000, 55, 857.
7. Schumann, P.; Collot, V.; Hommet, Y.; Gsell, W.; Dauphin, F.; Sopkova, J.; MacKenzie, E. T.; Duval, D.; Boulouard, M.; Rault, S. Bioorg. Med. Chem. Lett. 2001, 11, 1153-1156.
8. Wrzeciono, U.; Linkowska, E.; Majewska, K.; Gzella, A.; Stochla, K. Pharmazie 1993, 48, 582-584.
9. Bistocchi, G. A.; De Meo, G.; Pedini, M.; Ricci, A.; Brouilhet, H.; Boucherie, S.; Rabaud, M.; Jacquignon, P. Farmaco Ed. Sci. 1981, 36, 315-333.
10. Fujimura, Y.; Ikeda, Y.; Matsunaga, I. Yakugaku Zasshi 1986, 106, 995-1001.
11. Baxendale, I. R.; Ley, S. V. Bioorganic & Medicinal Chemistry Letters 2000, 10, 1983-1986.
12. Claramunt, R. M.; Elguero, J.; Garceran, R. Heterocycles 1985, 23, 2895-2906.
13. Baiocchi, L.; Corsi, G.; Palazzo, G. Synthesis 1978, 633-648.
14. Pillai, S. P.; Pillai, C. A.; Shankel, D. M.; Mitscher, L. A. Mutation Res. 2001, 496, 61-73.
15. Hinman, R. L.; Fulton, D. J. Am. Chem. Soc. 1958, 80, 1895-1900.
16. Katritzky, A. R.; Boulton, A. J.; Fletcher, I. J. J. Chem. Soc. C. 1971, 7, 1193-1196.
17. Mosti, L.; Sansebastiano, L.; Fossa, P.; Schenone, P.; Mattioli, F. Farmaco 1992, 47, 357-365.
18. Frank, K. E.; Jung, M.; Mitscher, L. A. Comb. Chem. High Throughput Screening 1998, 1, 73.
19. Testa, M.; Iuliano, G.; Marino, E.; Buongiovanni, C.; Paolercio, F.; Trapanese, A.; Mortow, P. J. Ocul. Pharmacol. 1986, 2, 251-266.
20. Maron, D.M.; Ames, B.N. Mutat. Res. 1983, 113, 173-215.